These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 15902435)

  • 1. Mice lacking the IFN-gamma receptor or fyn develop severe experimental autoimmune uveoretinitis characterized by different immune responses.
    Fukushima A; Yamaguchi T; Ishida W; Fukata K; Udaka K; Ueno H
    Immunogenetics; 2005 Jun; 57(5):337-43. PubMed ID: 15902435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of experimental autoimmune uveoretinitis by anti-delta-like ligand 4 monoclonal antibody.
    Ishida W; Fukuda K; Sakamoto S; Koyama N; Koyanagi A; Yagita H; Fukushima A
    Invest Ophthalmol Vis Sci; 2011 Oct; 52(11):8224-30. PubMed ID: 21896864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differentiation of Th1 and Th2 cells in lymph nodes and spleens of mice during experimental autoimmune uveoretinitis.
    Takeuchi M; Yokoi H; Tsukahara R; Sakai J; Usui M
    Jpn J Ophthalmol; 2001; 45(5):463-9. PubMed ID: 11583666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-18 not required for IRBP peptide-induced EAU: studies in gene-deficient mice.
    Jiang HR; Wei X; Niedbala W; Lumsden L; Liew FY; Forrester JV
    Invest Ophthalmol Vis Sci; 2001 Jan; 42(1):177-82. PubMed ID: 11133864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blockade of interleukin-6 signaling suppresses not only th17 but also interphotoreceptor retinoid binding protein-specific Th1 by promoting regulatory T cells in experimental autoimmune uveoretinitis.
    Haruta H; Ohguro N; Fujimoto M; Hohki S; Terabe F; Serada S; Nomura S; Nishida K; Kishimoto T; Naka T
    Invest Ophthalmol Vis Sci; 2011 May; 52(6):3264-71. PubMed ID: 21330657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delayed onset and decreased severity of experimental autoimmune uveoretinitis in mice lacking nitric oxide synthase type 2.
    Thillaye-Goldenberg B; Goureau O; Naud MC; de Kozak Y
    J Neuroimmunol; 2000 Oct; 110(1-2):31-44. PubMed ID: 11024532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intraocular cytokine quantification of experimental autoimmune uveoretinitis in rats.
    Okada AA; Sakai J; Usui M; Mizuguchi J
    Ocul Immunol Inflamm; 1998 Jun; 6(2):111-20. PubMed ID: 9689641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Expression of suppressor of cytokine signaling in retina of experimental autoimmune uveoretinitis].
    Wang H; Zhou ZC; Peng XY; Zhao M
    Zhonghua Yan Ke Za Zhi; 2008 Oct; 44(10):876-82. PubMed ID: 19176113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SLAT/Def6 plays a critical role in the pathogenic process of experimental autoimmune uveitis (EAU).
    Vistica BP; Shi G; Nugent L; Tan C; Altman A; Gery I
    Mol Vis; 2012; 18():1858-64. PubMed ID: 22815639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endogenous IL-12 is required for induction and expression of experimental autoimmune uveitis.
    Tarrant TK; Silver PB; Chan CC; Wiggert B; Caspi RR
    J Immunol; 1998 Jul; 161(1):122-7. PubMed ID: 9647215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CCR5-deficient mice develop experimental autoimmune uveoretinitis in the context of a deviant effector response.
    Takeuchi A; Usui Y; Takeuchi M; Hattori T; Kezuka T; Suzuki J; Okunuki Y; Iwasaki T; Haino M; Matsushima K; Usui M
    Invest Ophthalmol Vis Sci; 2005 Oct; 46(10):3753-60. PubMed ID: 16186359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential roles for IFN-gamma and IL-17 in experimental autoimmune uveoretinitis.
    Yoshimura T; Sonoda KH; Miyazaki Y; Iwakura Y; Ishibashi T; Yoshimura A; Yoshida H
    Int Immunol; 2008 Feb; 20(2):209-14. PubMed ID: 18156624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Invariant natural killer T cells play dual roles in the development of experimental autoimmune uveoretinitis.
    Satoh M; Namba KI; Kitaichi N; Endo N; Kitamei H; Iwata D; Ohno S; Ishida S; Onoé K; Watarai H; Taniguchi M; Ishibashi T; Stein-Streilein J; Sonoda KH; Van Kaer L; Iwabuchi K
    Exp Eye Res; 2016 Dec; 153():79-89. PubMed ID: 27720708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulatory effects of IFN-β on the development of experimental autoimmune uveoretinitis in B10RIII mice.
    Sun M; Yang Y; Yang P; Lei B; Du L; Kijlstra A
    PLoS One; 2011 May; 6(5):e19870. PubMed ID: 21573074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exogenous nitric oxide inhibits experimental autoimmune uveoretinitis development in Lewis rats by modulation of the Th1-dependent immune response.
    Kwak HJ; Yang YS; Pae HO; Kim YM; Chung HT
    Mol Cells; 2001 Oct; 12(2):178-84. PubMed ID: 11710518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leucine-Rich Repeat Kinase 2 (Lrrk2) Deficiency Diminishes the Development of Experimental Autoimmune Uveitis (EAU) and the Adaptive Immune Response.
    Wandu WS; Tan C; Ogbeifun O; Vistica BP; Shi G; Hinshaw SJ; Xie C; Chen X; Klinman DM; Cai H; Gery I
    PLoS One; 2015; 10(6):e0128906. PubMed ID: 26067490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinetics of intraocular cytokines in the suppression of experimental autoimmune uveoretinitis by type I IFN.
    Okada AA; Keino H; Suzuki J; Sakai J; Usui M; Mizuguchi J
    Int Immunol; 1998 Dec; 10(12):1917-22. PubMed ID: 9885913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Behavioral Conditioning of Immune Responses with Cyclosporine A in a Murine Model of Experimental Autoimmune Uveitis.
    Bauer D; Busch M; Pacheco-López G; Kasper M; Wildschütz L; Walscheid K; Bähler H; Schröder M; Thanos S; Schedlowski M; Heiligenhaus A
    Neuroimmunomodulation; 2017; 24(2):87-99. PubMed ID: 28848192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. S-nitrosoglutathione prevents interphotoreceptor retinoid-binding protein (IRBP(161-180))-induced experimental autoimmune uveitis.
    Haq E; Rohrer B; Nath N; Crosson CE; Singh I
    J Ocul Pharmacol Ther; 2007 Jun; 23(3):221-31. PubMed ID: 17593005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The requirement for pertussis to induce EAU is strain-dependent: B10.RIII, but not B10.A mice, develop EAU and Th1 responses to IRBP without pertussis treatment.
    Silver PB; Chan CC; Wiggert B; Caspi RR
    Invest Ophthalmol Vis Sci; 1999 Nov; 40(12):2898-905. PubMed ID: 10549650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.